DreaMed
Company Details
Status: Private
Employees: 11-50
Location:
14 Kaplan St, Institute for Endocrinology and Diabetes, Suite 20. POB 3271, Petah Tikva, Mercaz 4920235, IL
Type:
sample
sample
Technology:
sample
sample
About: Founded in 2014, our company pioneered the first artificial pancreas technology. Since then, DreaMed has dedicated itself to developing decision-support tools in the diabetes management field. We are the world's first and only company to receive FDA clearance for a decision support system that utilizes data from CGM/SMBG (continuous glucose monitoring/self-monitoring of blood glucose) and insulin pumps.
Our founders are all physicians and engineers. Our products are developed based on real insights from the clinical practice of diabetes specialists, physicians, and clinical researchers from the top diabetes centers worldwide. We prioritize privacy, security, quality, and regulatory compliance, operating under a stringent quality management system and adhering to ISO 27001, GDPR, and HIPAA standards. Additionally, our product FDA-cleared.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
DreaMed | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.